Effects of the Dipeptidyl Peptidase 4 Inhibitor Alogliptin on Blood Pressure in Hypertensive Patients with Type 2 Diabetes Mellitus-Reference-Cited by-同舟云学术

Effects of the Dipeptidyl Peptidase 4 Inhibitor Alogliptin on Blood Pressure in Hypertensive Patients with Type 2 Diabetes Mellitus

Published:2019-05-02 Issue:7 Volume:32 Page:695-702
ISSN:0895-7061
Container-title:American Journal of Hypertension
language:en
Short-container-title:

Author:

Kishimoto Shinji¹,Kinoshita Yoshihiko²,Matsumoto Takeshi³,Maruhashi Tatsuya⁴,Kajikawa Masato⁵,Matsui Shogo⁴,Hashimoto Haruki⁴,Takaeko Yuji⁴,Kihara Yasuki⁴,Chayama Kazuaki⁶,Goto Chikara⁷,Mohamad Yusoff Farina¹,Nakashima Ayumu⁸,Noma Kensuke¹,Higashi Yukihito¹⁵

Affiliation:

1. Department of Cardiovascular Regeneration and Medicine, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan

2. Kinoshita Clinic, Hiroshima, Japan

3. Department of Cardiovascular Medicine, Onomichi General Hospital, Hiroshima, Japan

4. Department of Cardiovascular Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan

5. Division of Regeneration and Medicine, Medical Center for Translational and Clinical Research, Hiroshima University Hospital, Hiroshima, Japan

6. Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan

7. Department of Rehabilitation, Faculty of General Rehabilitation, Hiroshima International University, Hiroshima, Japan

8. Department of Stem Cell Biology and Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan

Funder

Scientific Research from the Ministry of Education, Science and Culture of Japan

Publisher

Oxford University Press (OUP)

Subject

Internal Medicine

Link

http://academic.oup.com/ajh/advance-article-pdf/doi/10.1093/ajh/hpz065/28648481/hpz065.pdf

Reference36 articles.

1. Epidemiology of cardiovascular complications in type 2 diabetes mellitus;Meigs;Acta Diabetol,2003

2. Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005;Preis;Circulation,2009

3. Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes;Rawshani;N Engl J Med,2018

4. Effect of a multifactorial intervention on mortality in type 2 diabetes;Gaede;N Engl J Med,2008

5. Long-term follow-up after tight control of blood pressure in type 2 diabetes;Holman;N Engl J Med,2008

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diabetes and seeds: New horizon to promote human nutrition and anti-diabetics compounds in grains by germination;Critical Reviews in Food Science and Nutrition;2022-04-20

2. The anti-diabetic drug alogliptin induces vasorelaxation via activation of Kv channels and SERCA pumps;European Journal of Pharmacology;2021-05

3. Effect of linagliptin on glucose metabolism and pancreatic beta cell function in patients with persistent prediabetes after metformin and lifestyle;Scientific Reports;2021-04-22

4. DPP4 inhibition mitigates ANG II-mediated kidney immune activation and injury in male mice;American Journal of Physiology-Renal Physiology;2021-03-01

5. Associations between continuous glucose monitoring-derived metrics and arterial stiffness in Japanese patients with type 2 diabetes;Cardiovascular Diabetology;2021-01-07